XTRA:FNTN
XTRA:FNTNWireless Telecom

European Dividend Stocks To Consider In January 2026

As we enter January 2026, the European markets are showing resilience, with the pan-European STOXX Europe 600 Index ending higher amid positive economic data and earnings results. In this environment of cautious optimism, investors may find dividend stocks appealing due to their potential for stable income and capital preservation during mixed market conditions.
XTRA:ALV
XTRA:ALVInsurance

Does Allianz’s Responsible AI Push with Anthropic and Wrisk Reshape Its Edge in Insurance Tech (XTRA:ALV)?

In early January 2026, Anthropic announced a global partnership with Allianz SE to roll out responsible AI across the insurer’s operations, while Allianz also invested in UK insurtech Wrisk as part of its Series B funding to support international expansion and data science development. Together, the Anthropic collaboration and Wrisk investment underline how Allianz is embedding advanced AI and data capabilities into both its internal processes and external innovation ecosystem. Next, we’ll...
XTRA:RHM
XTRA:RHMAerospace & Defense

Why Rheinmetall (XTRA:RHM) Is Down 6.4% After JPMorgan Calls Defence Stock Pullback A Buying Opportunity And Highlights Capacity And Sustainability Shifts

In recent days, Rheinmetall has drawn attention as JPMorgan analysts framed the pullback in European defence stocks as a buying opportunity, against a backdrop of rising geopolitical tensions and expanded defence budgets. At the same time, Rheinmetall’s move to adopt decarbonized steel and its expanding artillery shell capacity highlight how sustainability and scale are reshaping its role within Europe’s defence industry. We’ll now examine how growing optimism about sustained defence...
XTRA:SHL
XTRA:SHLMedical Equipment

A Look At Siemens Healthineers (XTRA:SHL) Valuation After New Avanos Co‑Marketing Agreement

Siemens Healthineers (XTRA:SHL) has drawn fresh attention after announcing a co-marketing agreement with Avanos Medical to pair its imaging systems with radiofrequency ablation tools for outpatient and interventional pain care providers. See our latest analysis for Siemens Healthineers. That co marketing move comes after Siemens Healthineers outlined plans for disciplined tuck in acquisitions at the recent J.P. Morgan Healthcare Conference. However, the 1 year total shareholder return of a...
XTRA:TKMS
XTRA:TKMSAerospace & Defense

Is TKMS & Co KGaA (XTRA:TKMS) Using AI Partnerships To Redefine Its Defense Tech Edge?

Earlier in January 2026, TKMS and Cohere signed a Teaming Agreement to explore applying advanced AI language and data-driven models to the Canadian Patrol Submarine Program, covering decision-support workflows, onboard information management, training, and secure naval interfaces under strict Canadian security and compliance requirements. This collaboration highlights TKMS’s push to embed Canadian firms in its supply chain and to pair submarine engineering expertise with enterprise AI...
XTRA:DR0
XTRA:DR0Oil and Gas

European Dividend Stocks To Consider In January 2026

As we enter 2026, the European market shows resilience with the pan-European STOXX Europe 600 Index gaining ground, buoyed by robust economic data and favorable earnings results. Against this backdrop of mixed performances across major indices such as Germany's DAX and France's CAC 40, investors may find dividend stocks appealing due to their potential for providing steady income streams amidst economic recovery.
XTRA:TKA
XTRA:TKAMetals and Mining

Thyssenkrupp (XTRA:TKA) Valuation In Focus As TKMS Defense Bid Lifts Investor Interest

Thyssenkrupp (XTRA:TKA) drew fresh investor attention after TKMS’s CEO outlined the group’s bid for a sizable Canadian defense contract, coinciding with a positive share move for both companies. See our latest analysis for thyssenkrupp. The TKMS contract news lands on top of strong momentum, with a 1 month share price return of 19.91% and a 1 year total shareholder return of 245.37%. This suggests interest has been building rather than fading. If this defense story has your attention, it...
XTRA:MUV2
XTRA:MUV2Insurance

Is Munich Re’s Thailand Leadership Move Reframing Its Underwriting Narrative for (XTRA:MUV2) Investors?

Munich Re AG has appointed Chotima Puasiri, formerly executive vice president of product management and underwriting strategy at ERGO Insurance (Thailand), as its new chief representative for Thailand, effective from March 1, 2026. This leadership change highlights Munich Re’s continued emphasis on strengthening its on-the-ground underwriting and product expertise in a key Southeast Asian insurance market. We will now examine how investor caution over reserve strengthening, alongside this...
XTRA:TUI1
XTRA:TUI1Hospitality

How Investors May Respond To TUI (XTRA:TUI1) Booking Rebound And Cash Flow Ahead Of 2026 Earnings

TUI recently saw strong investor interest following reports of a steady recovery in holiday bookings and improving cash flow metrics, ahead of its scheduled earnings release on 10 February 2026. This combination of operational progress and an upcoming results catalyst has sharpened focus on how effectively TUI is converting higher demand into healthier balance sheet trends. With recent share price gains over both one and seven days, we’ll explore how improving bookings reshape TUI’s broader...
XTRA:BAS
XTRA:BASChemicals

Is BASF (XTRA:BAS) Pricing Misaligned After Regulatory News And Mixed Long Term Returns

If you are wondering whether BASF's current share price reflects its true worth, this article will walk through what the numbers are actually saying about value. BASF's shares last closed at €46.43, with returns of 0.3% over the past week, 6.4% over the past month, 3.7% year to date, 7.0% over one year, 7.2% over three years and a 1.7% decline over five years. Taken together, these figures give you a mixed picture of recent and longer term performance. Recent news around BASF has focused on...
XTRA:P911
XTRA:P911Auto

Is Porsche (XTRA:P911) Starting To Look Interesting After A 1 Year Share Price Slide

If you have been wondering whether Dr. Ing. h.c. F. Porsche shares are starting to look interesting on price alone, this article walks through what the current market price might be implying about value. The stock last closed at €41.54, with returns of a 4.7% decline over 7 days, an 8.7% decline over 30 days, a 12.7% decline year to date, and a 26.9% decline over 1 year. The 3 year return stands at a 56.3% decline. These moves have come against a backdrop of ongoing market attention on...
XTRA:JUN3
XTRA:JUN3Machinery

AntOn Value Launch in Asia-Pacific Might Change The Case For Investing In Jungheinrich (XTRA:JUN3)

Jungheinrich has launched "AntOn by Jungheinrich" in the Asia-Pacific region, introducing a value-focused brand offering lithium-ion forklift trucks and a pallet truck as the first step toward a broader material handling range. This new brand extends Jungheinrich’s portfolio into the value segment of Asia-Pacific material handling, aligning with its Strategy 2030+ and targeting customers prioritizing cost-effective reliability. We will now examine how this Asia-Pacific launch of a...
XTRA:SY1
XTRA:SY1Chemicals

Large Non‑Cash Impairments And Portfolio Moves Might Change The Case For Investing In Symrise (XTRA:SY1)

Symrise AG has recorded non-cash impairment charges of about €145 million on its terpenes business and €150 million on its investment in Swedencare AB, both booked in the fourth quarter of 2025 and linked to a planned sale process and application of IFRS 5. The company also plans to present at the 25th German Corporate Conference in Frankfurt, giving management an opportunity to explain how these impairments and portfolio moves affect its financial profile and business focus. Next, we’ll...
XTRA:BOSS
XTRA:BOSSLuxury

Assessing Hugo Boss (XTRA:BOSS) Valuation After Extended Share Price Weakness

Recent share performance and business snapshot Hugo Boss (XTRA:BOSS) has been under pressure recently, with the share price showing declines over the past week, month and past 3 months, as well as over the past year. At a last close of €34.19, the company reports annual revenue of €4,238.349 and net income of €224.468, with both revenue and net income growth figures described on an annual basis. See our latest analysis for Hugo Boss. The recent 1 day and 1 month share price returns, alongside...
XTRA:CBK
XTRA:CBKBanks

Is Commerzbank (XTRA:CBK) Still Attractively Priced After Nearly Doubling In One Year?

If you are wondering whether Commerzbank’s share price still offers value after a strong run, you are in the right place to look at what the numbers actually say. The stock last closed at €34.26, with a 7 day return of 4.9% decline, a 30 day return of 3.7% decline, a year to date return of 5.9% decline, a 1 year return of 97.7% and a 3 year return of 281.7%. Recent coverage has focused on Commerzbank’s position within the German banking sector and how market expectations are being reflected...
XTRA:ACX
XTRA:ACXHospitality

3 European Penny Stocks With Market Caps Under €60M

The European market has shown resilience, with the pan-European STOXX Europe 600 Index ending 0.77% higher, driven by solid economic data and earnings results. Penny stocks, though often considered a relic of past market eras, continue to hold potential for investors seeking growth opportunities at lower price points. These stocks typically represent smaller or newer companies that can offer a blend of affordability and growth potential when supported by strong financials.
XTRA:BEI
XTRA:BEIPersonal Products

Did Beiersdorf’s (XTRA:BEI) HIPS Microbiome Tie-Up Just Reframe Its Skincare Innovation Strategy?

Beiersdorf recently entered an exclusive research partnership with the Helmholtz Centre for Infection Research’s HIPS institute to investigate how the skin microbiome contributes to maintaining healthy skin, building on large microbiome and genomic datasets originally developed for infectious disease research. The collaboration, which already includes two funded projects and room for expansion, could strengthen Beiersdorf’s innovation pipeline by grounding future skincare concepts in...
XTRA:RHM
XTRA:RHMAerospace & Defense

Rheinmetall Ramps Up European Defense Production As Valuation Draws Interest

European defense production is ramping up sharply as geopolitical tensions rise, including new tariff frictions between the US and Europe tied to Greenland. European governments are committing to higher defense spending, drawing fresh investor attention to defense names such as Rheinmetall (XTRA:RHM). Rheinmetall is expanding ammunition production capacity, with output levels that can exceed some US peers, signaling a major build out in European firepower. Rheinmetall (XTRA:RHM) sits at the...